Drilldown: Medicines
Medicines > fda max:
10 mg/d (5 mg if severe renal or moderate hepatic impairment, or strong CYP3A4 inhibitors) 
& onset :
BP and symptomatic LUTS improvement within 1-2 weeks or
Postprandial glucose effect within days; HbA1c by 12 weeks
& onset :
BP and symptomatic LUTS improvement within 1-2 weeks or
Postprandial glucose effect within days; HbA1c by 12 weeks Use the filters below to narrow your results.
generic:
(There are no values for this filter)
brand:
(There are no values for this filter)
classes:
(There are no values for this filter)
mechanism:
(There are no values for this filter)
uses:
(There are no values for this filter)
starting dose:
(There are no values for this filter)
preparations:
(There are no values for this filter)
fda max: (Click arrow to add another value)
routes:
(There are no values for this filter)
onset: (Click arrow to add another value)
duration:
(There are no values for this filter)
halflife:
(There are no values for this filter)
bioavailability:
(There are no values for this filter)
pregnancy:
(There are no values for this filter)
legal:
(There are no values for this filter)
There are no results for this report.